RFP-32812-01591 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-06
Dose 1 — Pfizer-BioNTech
2021-02-08
Registered in v-safe
2021-02-08
Survey response — days 1–6 daily, dose 1
MedDRA: Nasal congestion — Feeling: Fair · Site: Pain

Free text: Nasal congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Survey response — days 1–6 daily, dose 1
MedDRA: Nasal congestion — Feeling: Fair · Headache

Free text: Nasal congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-10
Survey response — days 1–6 daily, dose 1
MedDRA: Nasal congestion — Feeling: Good

Free text: Nasal congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-27
Dose 2 — Pfizer-BioNTech
2021-02-28
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-06	Pfizer-BioNTech
2	2021-02-27	Pfizer-BioNTech

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-08

Systemic reaction (other): Nasal congestion

2021-02-09

Systemic reaction (other): Nasal congestion

Release 4 — days 1–6 daily, dose 1

2021-02-10

Systemic reaction (other): Nasal congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Nasal congestion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release